Medicare Advantage Payments Lifted

The United States government has announced a significant upward revision to payments for private insurers offering Medicare Advantage plans, increasing the reimbursement rate for 2027 to an average of 2.48%. The decision marks a notable shift from the near-flat adjustment proposed in January and has triggered a strong rally in health insurance stocks.

According to the Centres for Medicare & Medicaid Services (CMS), insurers will also benefit from an additional 2.5% increase linked to changes in risk adjustment methodology, which reflects the health status of enrollees. Combined, the overall uplift is estimated at approximately 5%, translating into more than $13 billion in additional payments to Medicare Advantage plans in 2027.

The revised outlook was well received by financial markets. Shares in major US health insurers, including UnitedHealth, Humana and CVS Health, rose sharply in extended trading, gaining between 8% and 14%. Investors had previously reacted negatively to January’s draft proposal, which suggested a minimal increase of just 0.09% for the same year.

Analysts described the final rule as a relief for the industry, noting that it provides clearer visibility on future medical cost trends. A Morningstar analyst said the updated rate structure offers insurers a more predictable framework for planning 2027 expenditures, particularly in relation to rising healthcare costs.

From an investment perspective, Bahl and Gaynor’s chief operating officer observed that the effective increase is closer to 3.5%–4% once broader methodological adjustments are considered. He characterised the outcome as broadly favourable, particularly given the temporary pause on further changes to the risk adjustment model.

CMS officials stated that the pause is intended to give insurers and healthcare providers time to adapt to longer-term structural reforms. The agency also highlighted shifts in the Medicare Advantage landscape, noting that some insurers have reduced participation in capitated payment models, while certain providers have exited network arrangements altogether.

Insurers had previously argued that the initial January proposal failed to adequately reflect ongoing inflationary pressures in medical services. Industry representatives reiterated that plans remain committed to maintaining affordability while managing rising costs.

A spokesperson for the industry group AHIP said that health plans would continue focusing on balancing access and affordability as they incorporate the latest policy changes.

The adjustment follows a similarly volatile policy cycle in the previous year. For 2026, the government ultimately finalised a 5.06% increase in Medicare Advantage reimbursement rates, significantly higher than the 2.2% initially proposed.

Medicare Advantage Payment Changes

The revised figures underscore continued volatility in US healthcare reimbursement policy, with significant implications for insurers, investors and beneficiaries alike.